fundvisualizer.com

GMO Global Equity Allocation IIIGMGEX

Performance (before sales charge)

As of 08/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 05/31/2022
Stock
33.60%
Non-U.S. Stock
59.32%
Bond
1.47%
Non-U.S. Bond
0.00%
Preferred
0.30%
Convertible
0.00%
Cash
-1.91%
Other
7.21%

Due to rounding, percentages may not equal 100%.

Sectors

As of 05/31/2022

Basic materials

0.00%

Consumer cyclical

0.00%

Financial services

0.00%

Real estate

0.00%

Consumer defensive

0.00%

Health care

0.00%

Utilities

0.00%

Communication services

0.00%

Energy

0.00%

Industrials

0.00%

Technology

0.00%

Top 10 holdings

As of 05/31/2022

GMO International Equity IV
34.51%
GMO Emerging Markets VI
15.75%
GMO Quality VI
13.96%
GMO US Small Cap Value VI
9.84%
GMO US Equity VI
9.26%
GMO Emerging Markets ex-China VI
7.85%
GMO Quality Cyclicals VI
4.96%
GMO-Usonian Japan Value Creation VI
3.82%
State Street Instl Treasury MMkt Invsmt
0.05%
Other Liability
0.01%
Fund assets

$1.32 Billion

Share class

C

Morningstar category

Global Large-Stock Value

Expense ratio

0.59%

Investment objective

World Stock

Documents